Wednesday, July 15, 2026

IBM stock | Option strangle

 With the market pricing in absolute chaos, it is time to adopt an “off with their heads” stance on high premiums. Since the stock has already endured a massive 25% structural re-rating, the majority of the downward momentum is likely exhausted. By selling the monthly August 21, 2026, 190/245 short strangle, we can collect a massive premium from terrified buyers, betting that the stock will quietly consolidate within its new post-revolutionary boundaries.

Premium Captured: ~$11.25 per strangle (as of the July 14, 2026, close). This represents a 5.18% standstill yield relative to the underlying stock price in just 38 days.

  • Downside Breakeven: $178.75 (approx. 17.6% below current price)
  • Upside Breakeven: $256.25 (approx. 18.1% above current price)

This trade relies on a wide, symmetrical margin of safety. To breach the lower barrier of $178.75 — a level not visited since early 2024 — IBM would need to drop an additional 18% from its already-shattered state. If forced to take assignment, you are establishing a long position at a steep historical discount. On the upside, reclaiming $256.25 would require IBM to recoup more than half of today’s historic sell-off before August expiration, an unlikely feat given the sudden enterprise freeze on software and consulting budgets.

As the dust settles on this Bastille Day blowout, the market has left the gates wide open for option sellers. The news is out, but panic has kept options premiums elevated. For those willing to capture the fear, the short strangle offers a high-probability path to watch the remaining premium slowly bleed away.

No comments:

Post a Comment